{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:46:58Z","timestamp":1790135218604,"version":"4.0.1"},"reference-count":43,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1210\/jc.2017-01314","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T18:10:36Z","timestamp":1502993436000},"page":"46-55","source":"Crossref","is-referenced-by-count":20,"title":["Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and Paragangliomas"],"prefix":"10.1210","volume":"103","author":[{"given":"Lucie","family":"Evenepoel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francien H","family":"van Nederveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Oudijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G","family":"Papathomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F","family":"Restuccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J T","family":"Belt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter W","family":"de Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Feelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston J H","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hamoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Maiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans K","family":"Ghayee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry W","family":"Shay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurel","family":"Perren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri J L M","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"van Eeden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Vroonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selda","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miikka","family":"Vikkula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winand N M","family":"Dinjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Persu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Korpershoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"issue":"2","key":"key\n\t\t\t\t20180105135306_B1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"key\n\t\t\t\t20180105135306_B2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/gim.2014.162","article-title":"Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations","volume":"17","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"key\n\t\t\t\t20180105135306_B3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5454","key":"key\n\t\t\t\t20180105135306_B4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","year":"2000","journal-title":"Science"},{"issue":"15","key":"key\n\t\t\t\t20180105135306_B5","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"5944","key":"key\n\t\t\t\t20180105135306_B6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma","volume":"325","year":"2009","journal-title":"Science"},{"issue":"3","key":"key\n\t\t\t\t20180105135306_B7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","year":"2000","journal-title":"Nat Genet"},{"issue":"9","key":"key\n\t\t\t\t20180105135306_B8","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"7","key":"key\n\t\t\t\t20180105135306_B9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","year":"2011","journal-title":"Nat Genet"},{"issue":"25","key":"key\n\t\t\t\t20180105135306_B10","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","article-title":"PHD2 mutation and congenital erythrocytosis with paraganglioma","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"key\n\t\t\t\t20180105135306_B11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00109-012-0967-z","article-title":"A novel EPAS1\/HIF2A germline mutation in a congenital polycythemia with paraganglioma","volume":"91","year":"2013","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"key\n\t\t\t\t20180105135306_B12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma","volume":"42","year":"2010","journal-title":"Nat Genet"},{"issue":"1","key":"key\n\t\t\t\t20180105135306_B13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","year":"2015","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"key\n\t\t\t\t20180105135306_B14","first-page":"djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"key\n\t\t\t\t20180105135306_B15","doi-asserted-by":"crossref","first-page":"E1376","DOI":"10.1210\/jc.2013-3879","article-title":"H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180105135306_B16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"20","key":"key\n\t\t\t\t20180105135306_B17","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"1","key":"key\n\t\t\t\t20180105135306_B18","first-page":"72","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","year":"2005","journal-title":"PLoS Genet"},{"issue":"12","key":"key\n\t\t\t\t20180105135306_B19","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1210\/me.2010-0256","article-title":"Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas","volume":"24","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"6","key":"key\n\t\t\t\t20180105135306_B20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","year":"2013","journal-title":"Cancer Cell"},{"issue":"5","key":"key\n\t\t\t\t20180105135306_B21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/gcc.22347","article-title":"HRAS mutation prevalence and associated expression patterns in pheochromocytoma","volume":"55","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"key\n\t\t\t\t20180105135306_B22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1530\/ERC-10-0184","article-title":"Overexpression of the natural antisense hypoxia-inducible factor-1alpha transcript is associated with malignant pheochromocytoma\/paraganglioma","volume":"18","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"key\n\t\t\t\t20180105135306_B23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1600-0463.2004.apm1120901.x","article-title":"Malignancy in pheochromocytomas","volume":"112","year":"2004","journal-title":"APMIS"},{"issue":"10","key":"key\n\t\t\t\t20180105135306_B24","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jc.2013-1907","article-title":"One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma","volume":"98","author":"French group of Endocrine and Adrenal tumors (Groupe des Tumeurs Endocrines-REseau NAtional des Tumeurs ENdocrines and COrtico-MEdullo Tumeurs Endocrines networks)","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180105135306_B25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1677\/erc.1.00829","article-title":"Malignant pheochromocytoma: current status and initiatives for future progress","volume":"11","year":"2004","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"key\n\t\t\t\t20180105135306_B26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Phaeochromocytoma Study Group in Japan","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"key\n\t\t\t\t20180105135306_B27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"key\n\t\t\t\t20180105135306_B28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","article-title":"Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score","volume":"33","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180105135306_B29","first-page":"541","article-title":"Gene expression profiling of benign and malignant pheochromocytoma","volume-title":"Ann N Y Acad Sci","year":"2006"},{"issue":"6","key":"key\n\t\t\t\t20180105135306_B30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/SLA.0b013e3181b248bb","article-title":"Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling","volume":"250","year":"2009","journal-title":"Ann Surg"},{"issue":"12","key":"key\n\t\t\t\t20180105135306_B31","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1210\/jc.2007-1253","article-title":"Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180105135306_B32","first-page":"181","article-title":"Cancer Genome Atlas Research N","volume-title":"Cancer Cell","year":"2017"},{"issue":"1","key":"key\n\t\t\t\t20180105135306_B33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","year":"2010","journal-title":"Bioinformatics"},{"issue":"8","key":"key\n\t\t\t\t20180105135306_B34","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","year":"2009","journal-title":"Lancet Oncol"},{"issue":"6","key":"key\n\t\t\t\t20180105135306_B35","doi-asserted-by":"crossref","first-page":"e65624","DOI":"10.1371\/journal.pone.0065624","article-title":"Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor","volume":"8","year":"2013","journal-title":"PLoS One"},{"issue":"14","key":"key\n\t\t\t\t20180105135306_B36","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1093\/nar\/gkp425","article-title":"An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia","volume":"37","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"key\n\t\t\t\t20180105135306_B37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1242\/bio.20133343","article-title":"Contactin 4, -5 and -6 differentially regulate neuritogenesis while they display identical PTPRG binding sites","volume":"2","year":"2013","journal-title":"Biol Open"},{"issue":"1","key":"key\n\t\t\t\t20180105135306_B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/glia.20254","article-title":"Contactin is expressed in human astrocytic gliomas and mediates repulsive effects","volume":"53","year":"2006","journal-title":"Glia"},{"issue":"5","key":"key\n\t\t\t\t20180105135306_B39","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1158\/0008-5472.CAN-05-2645","article-title":"Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma","volume":"66","year":"2006","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180105135306_B40","unstructured":"Yu\n            JW\n          , WuSH, LuRQ, WuJG, NiXC, ZhouGC, JiangHG, ZhengLH, LiXQ, DuGY, JiangBJ. Expression and significances of contactin-1 in human gastric cancer. Gastroenterol Res Pract. 2013;2013:210205."},{"issue":"3","key":"key\n\t\t\t\t20180105135306_B41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.molcel.2015.06.020","article-title":"ERK2 mediates metabolic stress response to regulate cell fate","volume":"59","year":"2015","journal-title":"Mol Cell"},{"issue":"5","key":"key\n\t\t\t\t20180105135306_B42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/(SICI)1097-0215(19981023)79:5<537::AID-IJC16>3.0.CO;2-Z","article-title":"Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomas","volume":"79","year":"1998","journal-title":"Int J Cancer"},{"issue":"3","key":"key\n\t\t\t\t20180105135306_B43","doi-asserted-by":"crossref","first-page":"e0121361","DOI":"10.1371\/journal.pone.0121361","article-title":"Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas","volume":"10","year":"2015","journal-title":"PLoS One"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/1\/46\/23270186\/jc.2017-01314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T23:32:52Z","timestamp":1515195172000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jcem\/article\/103\/1\/46\/4083502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,8,17]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-01314","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,8,17]]}}}